F471-0141 Screening compound: 2-[2-(4-ethoxyphenyl)-2-oxoethyl]-N-(2-methylpropyl)-1,5-dioxo-4-propyl-1H,2H,4H,5H-[1,2,4]triazolo[4,3-a]quinazoline-8-carboxamide

F471-0141 Screening compound: 2-[2-(4-ethoxyphenyl)-2-oxoethyl]-N-(2-methylpropyl)-1,5-dioxo-4-propyl-1H,2H,4H,5H-[1,2,4]triazolo[4,3-a]quinazoline-8-carboxamide
F471-0141 Screening compound: 2-[2-(4-ethoxyphenyl)-2-oxoethyl]-N-(2-methylpropyl)-1,5-dioxo-4-propyl-1H,2H,4H,5H-[1,2,4]triazolo[4,3-a]quinazoline-8-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F471-0141
2-[2-(4-ethoxyphenyl)-2-oxoethyl]-N-(2-methylpropyl)-1,5-dioxo-4-propyl-1H,2H,4H,5H-[1,2,4]triazolo[4,3-a]quinazoline-8-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F471-0141

Molecular Formula

C27H31N5O5 (C27 H31 N5 O5)

Compound Name

2-[2-(4-ethoxyphenyl)-2-oxoethyl]-N-(2-methylpropyl)-1,5-dioxo-4-propyl-1H,2H,4H,5H-[1,2,4]triazolo[4,3-a]quinazoline-8-carboxamide

IUPAC name

2-[2-(4-ethoxyphenyl)-2-oxoethyl]-N-(2-methylpropyl)-15-dioxo-4-propyl-1H2H4H5H-[124]triazolo[43-a]quinazoline-8-carboxamide

SMILES

CCCN(C(N1c2c3ccc(C(NCC(C)C)=O)c2)=NN(CC(c(cc2)ccc2OCC)=O)C1=O)C3=O

InChI

InChI=1S/C27H31N5O5/c1-5-13-30-25(35)21-12-9-19(24(34)28-15-17(3)4)14-22(21)32-26(30)29-31(27(32)36)16-23(33)18-7-10-20(11-8-18)37-6-2/h7-12,14,17H,5-6,13,15-16H2,1-4H3,(H,28,34)

InChI Key

VLFZALNVPQHOEW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27132057

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

505.57

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.266

Distribution Coefficient, logD

3.266

Water Solubility, LogSw

-3.69

Polar Surface Area

93.241

Acid Dissociation Constant (pKa)

14.29

Base Dissociation Constant (pKb)

-2.65

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.00

F471-0141 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • Kinases
  • Others
  • GPCR
Mechanism of action:
  • Epigenetic
  • Receptor's ligands
  • Epigenetic

References: we are preparing a list of scientific research reports with F471-0141 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F471-0141?
Check Price and Availability of F471-0141, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F471-0141 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F471-0141
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F471-0141
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F471-0141 available by request